Skip to main content
Equibles

Swiss National Bank

Bank

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1582202 ZURICH, V8
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$3,459,342
+$766,952 QoQ
Shares Held
942,600
+7.5% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 344 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. RXRX ranks #83 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in RXRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,459,342 942,600
2026-03-31 $2,692,390 877,000
2025-12-31 $2,946,027 720,300
2025-09-30 $3,028,528 620,600
2025-06-30 $2,864,972 566,200
2025-03-31 $2,556,657 483,300
2024-12-31 $3,290,092 486,700
2024-09-30 $2,353,289 357,100
2024-06-30 $2,664,000 355,200
2024-03-31 $3,075,745 308,500
2023-12-31 $2,774,604 281,400
2023-09-30 $2,173,365 284,100
2023-06-30 $2,087,865 279,500
2023-03-31 $784,392 117,600
2022-12-31 $922,116 119,600
2022-09-30 $1,239,560 116,500
2022-06-30 $918,192 112,800
2022-03-31 $675,188 94,300
2021-12-31 $1,500,588 87,600